Hemosiderosis classification: Difference between revisions
Jump to navigation
Jump to search
(Page Creation/Layout) |
|||
Line 7: | Line 7: | ||
==Classification== | ==Classification== | ||
*[[IPH]] may be grouped into three categories based on disease characteristic: | |||
:*Group 1 pulmonary hemosiderosis involves PH with circulating anti-GMB antibodies. | |||
:*Group 2 pulmonary hemosiderosis involves PH with an immune complex disease such as systemic lupus erythematosus, SLE. | |||
:*Group 3 pulmonary hemosiderosis involves no demonstrable immune system involvement. | |||
==References== | ==References== |
Revision as of 03:14, 28 September 2020
Hemosiderosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemosiderosis classification On the Web |
American Roentgen Ray Society Images of Hemosiderosis classification |
Risk calculators and risk factors for Hemosiderosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Classification
- IPH may be grouped into three categories based on disease characteristic:
- Group 1 pulmonary hemosiderosis involves PH with circulating anti-GMB antibodies.
- Group 2 pulmonary hemosiderosis involves PH with an immune complex disease such as systemic lupus erythematosus, SLE.
- Group 3 pulmonary hemosiderosis involves no demonstrable immune system involvement.